1. P222 Input of a patient advisory group into evaluating the benefit: risk profile of existing and potential copd therapies. (15th November 2016) Authors: Burrage, DR; Tumilty, M; Ruickbie, S; Baker, EH Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P69 Are patients with chronic obstructive pulmonary disease receiving the best treatment for their cardiovascular risk factors?. (December 2018) Authors: Masteva, H; Baker, EH; Burrage, DR Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P98 Grey matter atrophy, retinal vessel dilatation & reduction in aortic distensibility in copd: the relationship between multi-organ vascular measures. (15th November 2017) Authors: Dodd, JW; Spilling, CA; Bajaj, M-PK; Burrage, DR; Ruickbie, S; McKay, GJ; Bucciarelli-Ducci, C; Baker, EH; Barrick, TR; Jones, PW Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗